# US 2026/0202305 A1 · Hematology flow system interface

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0202305 A1
- Document ID: US20260202305A1
- Status: Published application
- Kind: A1
- Application number: 19/136,267
- Filed: 2023-12-05
- Published: 2026-07-16
- Earliest claimed: 2022-12-05
- Assignees: Beckman Coulter, Inc.
- Applicants: Beckman Coulter, Inc.
- Inventors: Bart WANDERS; John ROCHE; Ken GOOD; Carol QUON; Linda GARLAUS; Rigoberto ROCHE
- Web page: https://patentgrep.com/patent/US20260202305A1

## CPC

- G01N 15/1433: using image recognition
- G01N 15/01: specially adapted for biological cells, e.g. blood cells (investigating sedimentation of particle suspensions in blood G01N15/05)
- G01N 15/1031: by measuring electrical or magnetic effects
- G01N 15/1436: {the optical arrangement forming an integrated apparatus with the sample container, e.g. a flow cell}
- G01N 15/1459: {the analysis being performed on a sample stream}
- G01N 15/147: {the analysis being performed on a sample stream}
- G01N 33/4915: {using flow cells (flow cytometry G01N15/14)}
- G01N 35/00613: {Quality control}
- G01N 35/00732: {Identification of carriers, materials or components in automatic analysers}
- G01N 35/00871: {Communications between instruments or with remote terminals}
- G01N 35/10: Devices for transferring samples {or any liquids} to, in, or from, the analysis apparatus, e.g. suction devices, injection devices {(G01N35/0099 takes precedence)}
- G01N 35/1095: {for supplying the samples to flow-through analysers (for a specific analyser see relevant groups, e.g. under G01N15/00, G01N21/00, G01N27/00, G01N30/00, H01J49/00)}
- G01N 2015/012: {Red blood cells}
- G01N 2015/014: {Reticulocytes}
- G01N 2015/016: {White blood cells}
- G01N 2015/018: {Platelets}
- G01N 2015/1006: {for cytology}
- G01N 2015/1026: {Recognising analyser failures, e.g. bubbles; Quality control for particle analysers}
- G01N 2015/144: {Imaging characterised by its optical setup}
- G01N 2015/1486: {Counting the particles}
- G01N 2015/1493: {Particle size}
- G01N 2015/1497: {Particle shape}
- G01N 2035/00752: {bar codes}
- G01N 2035/00762: {magnetic code}
- G01N 2035/00782: {reprogrammmable code}
- G01N 2035/00801: {Holders for sample carriers, e.g. trays, caroussel, racks}
- G01N 2035/00881: {network configurations}
- G01N 2035/00891: {Displaying information to the operator}
- G01N 2035/0091: {GUI [graphical user interfaces]}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A sample analysis system may comprise a flowcell, a fluidics system, an image capture device, and a processor. In such a system, the fluidics system may be adapted to flow a portion of a sample through the flowcell, and the image capture device may be configured to capture a plurality of images of blood cells in the flowcell. The processor may be programmed to perform a plurality of acts, including generating result data, displaying an interface operable to a user to select parameters, and displaying information corresponding to a review indication of the blood cells or the sample.

## Claims

### Claim 1

A sample analysis system comprising:
a) a flowcell;
b) a fluidics system adapted to flow a portion of a sample through the flowcell;
c) an image capture device configured to capture a plurality of images of blood cells as the blood cells pass through the flowcell; and
d) one or more processors, the one or more processors programmed to perform acts comprising:
i) analyzing the plurality of images to determine if a review indication applies to the plurality of images;
ii) display an interface with the review indication and a description of the review indication; and
iii) display the interface with at least one cell image corresponding to the review indication.

### Claim 2 (depends on 1)

The sample analysis system of claim 1, wherein the one or more processors are configured to determine that a user-defined review condition is satisfied; and, in response to determining that the user-defined review condition is satisfied, display the interface with the review indication.

### Claim 3 (depends on 1)

The sample analysis system of claim 1, wherein the review indication is at least one of: a high count indication, or a low count indication.

### Claim 4 (depends on 1)

The sample analysis system of claim 1, wherein the one or more processors are configured to determine that the review indication should be displayed based on satisfaction of a built in review condition.

### Claim 5 (depends on 1)

The sample analysis system of claim 1, wherein the one or more processors are configured to determine that the review indication should be displayed based on at least one of: a low confidence condition being satisfied, and a linearity condition not being satisfied.

### Claim 6 (depends on 1)

The sample analysis system of claim 1, wherein the one or more processors are programmed to determine that the review indication should be displayed based on detecting, in the plurality of images of blood cells, at least one of: platelet clumps or red blood cell clumps.

### Claim 7 (depends on 1)

The sample analysis system of claim 1, wherein the one or more processors are programmed to determine that the review indication should be displayed based on detecting, in the plurality of images of blood cells, at least one of: red blood cell fragments, sickle cells, dimorphic cells, large platelets, giant platelets, reticulated red blood cells, variant lymphocytes, or blast cells.

### Claim 8 (depends on 1)

The sample analysis system of claim 1, wherein the interface comprises a plurality of review indications and wherein the interface displays a description of each review indication and at least one cell image corresponding to each review indication.

### Claim 9 (depends on 1)

The sample analysis system of claim 1, further comprising a non-transitory computer readable medium having stored thereon a machine learning algorithm trained to analyze the images from the plurality of images to classify particles depicted in those images, wherein the one or more processors are programmed to determine that the review indication applies to the plurality of images based on confidence scores provided by the machine learning algorithm for classifications of particles depicted in the plurality of images.

### Claim 10 (depends on 1)

The sample analysis system of claim 1, further comprising a non-transitory computer readable medium storing a plurality of conditions for determining if corresponding review indications should be provided, wherein the plurality of conditions comprises a set of user defined conditions modifiable by users of the sample analysis system, and a set of built in conditions not modifiable by users of the sample analysis system.

### Claim 11 (depends on 10)

The sample analysis system of claim 10, wherein:
a) each user defined from the set of user defined conditions is associated with a particular cell type;
b) the set of user defined conditions comprise a first set of high and low thresholds for a particular cell type and a second set of high and low thresholds for the particular cell type;
c) the one or more processors are programmed to:
i) determine that a first review indication applies to the plurality of images when a count of the particular cell type is outside of the first set of high and low thresholds and contained within the second set of high and low thresholds; and
ii) determine that a second review indication applies to the plurality of images when the count for the particular cell type is outside of the second set of high and low thresholds;
and
d) the first and second review indications are visually distinguishable from each other.

### Claim at position 12

12-15. (canceled)

### Claim 16

A sample analysis method comprising:
a) using a fluidics system, flowing a portion of a sample through a flowcell;
b) using an image capture device, capturing a plurality of images of blood cells as the blood cells pass through the flowcell;
c) using one or more processors, performing a set of acts comprising:
i) analyzing the plurality of images to determine if a review indication applies to the plurality of images;
ii) displaying an interface with the review indication and a description of the review indication;
iii) displaying the interface with at least one cell image corresponding to the review indication.

### Claim 17 (depends on 16)

The sample analysis method of claim 16, wherein the method comprises determining that a user-defined review condition is satisfied; and wherein displaying the interface is performed in response to determining that the user-defined review condition is satisfied.

### Claim 18

(canceled)

### Claim 19 (depends on 16)

The sample analysis method of claim 16, wherein analyzing the plurality of images to determine if the review indication applies to the plurality of images comprises determining that the review indication should be displayed based on satisfaction of a built in review condition.

### Claim 20 (depends on 16)

The sample analysis method of claim 16, wherein analyzing the plurality of images to determine if the review indication applies to the plurality of images comprises determining that the review indication should be displayed based on at least one of: a low confidence condition being satisfied, and a linearity condition not being satisfied.

### Claim 21 (depends on 16)

The sample analysis method of claim 16, wherein analyzing the plurality of images to determine if the review indication applies to the plurality of images comprises determining that the review indication should be displayed based on detecting, in the plurality of images of blood cells, at least one of: platelet clumps or red blood cell clumps.

### Claim 22

(canceled)

### Claim 23 (depends on 16)

The sample analysis method of claim 16, wherein the interface comprises a plurality of review indications and wherein the interface displays a description of each review indication and at least one cell image corresponding to each review indication.

### Claim 24 (depends on 16)

The sample analysis method of claim 16, wherein analyzing the plurality of images to determine if the review indication applies to the plurality of images comprises:
a) using a machine learning algorithm trained to analyze the images from the plurality of images to classify particles depicted in those images; and
b) determining that the review indication applies to the plurality of images based on confidence scores provided by the machine learning algorithm for classifications of particles depicted in the plurality of images.

### Claim 25 (depends on 16)

The sample analysis method of claim 16, wherein analyzing the plurality of images to determine if the review indication applies to the plurality of images comprises retrieving, from a non-transitory computer readable medium, a plurality of conditions for determining if corresponding review indications should be provided, wherein the plurality of conditions comprises a set of user defined conditions modifiable by users of a sample analysis system, and a set of built in conditions not modifiable by users of the sample analysis system.

### Claim at position 23

26-45. (canceled)

### Claim 46

A sample analysis system comprising:
one or more processors; and
one or more non-transitory computer readable mediums storing instructions to, when executed, perform a set of acts comprising:
flowing a portion of a sample through the flowcell;
capturing a plurality of images of blood cells as the blood cells pass through the flowcell;
analyzing the plurality of images to determine if a review indication applies to the plurality of images;
displaying an interface with the review indication and a description of the review indication; and
displaying the interface with at least one cell image corresponding to the review indication.
